| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$500,000 ) |
| | 2024 | 2021 | SURROZEN INC | 171 OYSTER POINT BLVD #400 | SOUTH SAN FRANCISCO | CA | 94080-1910 | SAN MATEO | USA | U01AA028951 | A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis | 000 | 2 | NIH | 12/5/2023 | -$500,000 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | SURROZEN INC | 171 OYSTER POINT BLVD #400 | SOUTH SAN FRANCISCO | CA | 94080-1910 | SAN MATEO | USA | U01AA028951 | A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis | 000 | 2 | NIH | 9/20/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $502,500 ) |
| | 2021 | 2021 | SURROZEN INC | 171 OYSTER POINT BLVD #400 | SOUTH SAN FRANCISCO | CA | 94080-1910 | SAN MATEO | USA | U01AA028951 | A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis | 001 | 2 | NIH | 9/10/2021 | $502,500 |
| | 2021 | 2020 | SURROZEN INC | 171 OYSTER POINT BLVD #400 | SOUTH SAN FRANCISCO | CA | 94080-1910 | SAN MATEO | USA | U01AA028951 | A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis | 000 | 1 | NIH | 8/17/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,005,000 ) |
| | 2020 | 2020 | SURROZEN INC | 171 OYSTER POINT BLVD #400 | SOUTH SAN FRANCISCO | CA | 94080-1910 | SAN MATEO | USA | U01AA028951 | A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis | 000 | 1 | NIH | 9/25/2020 | $1,005,000 |
|
|
